Inhibition of clinically significant bacterial organisms in vitro by 2-acetylpyridine thiosemicarbazones.

AUTOR(ES)

Dobek, A S

RESUMO

Antibacterial activity of 65 2-acetylpyridine thiosemicarbazones and related compounds was determined by using clinical isolates of nine bacterial genera. Minimal inhibitory concentrations (MICs) of 0.002 to 0.062 micrograms/ml were obtained with 23% of the compounds for Neisseria gonorrhoeae and 0.016 to 0.062 micrograms/ml with 17% of the compounds for N. meningitidis. Staphylococcus aureus was inhibited in the MIC range of 0.125 to 0.5 micrograms/ml by 18% of the thiosemicarbazones, whereas 26% inhibited group D enterococcus with an MIC of 0.25 to 2.0 micrograms/ml. Poor antibacterial activity was shown toward the gram-negative bacilli, i.e., Pseudomonas, Klebsiella-Enterobacter, Shigella, Escherichia coli, and Proteus.

Documentos Relacionados

• Inhibition of Clinically Significant Bacterial Organisms In Vitro by 2-Acetylpyridine Thiosemicarbazones
• In vitro susceptibility of Neisseria gonorrhoeae to 2-acetylpyridine thiosemicarbazones.
• Activity of 2-acetylpyridine thiosemicarbazones against Trypanosoma rhodesiense in vitro.
• In vitro assessment of 2-acetylpyridine thiosemicarbazones against chloroquine-resistant Plasmodium falciparum.
• Antiviral Activity of 2-Acetylpyridine Thiosemicarbazones Against Herpes Simplex Virus